infectious diseases
Human Immunodeficiency Virus (HIV) Infection
More Information
The following English-language resources may be useful. Please note that The Manual is not responsible for the content of these resources. CDC 2022 Immunization Schedule: Recommended adult immunization schedule by medical condition and other indications Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents: Drug-Drug Interactions: Information regarding pharmacokinetic (PK) drug-drug interactions between antiretroviral (ARV) drugs and concomitant medications that are common and may lead to increased or decreased drug exposure Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: Recommendations for a public health approach - December 2014 supplement to the 2013 consolidated ARV guidelines National Institutes of Health's AIDSInfo: HIV-related research information from the NIH’s Office of AIDS Research (OAR), the National Institute Of Allergy and Infectious Diseases (NIAID), and the U.S. National Library of Medicine (NLM) CDC: Post-Exposure Prophylaxis (PEP): Resources for providers and consumer regarding the use of antiretroviral drugs after a single high-risk event to stop HIV seroconversion Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America: Evidence-based guidelines for the management of people infected with HIV Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis (PEP): Updated recommendations regarding HIV PEP regimens and the duration of HIV follow-up testing for exposed personnel Revised Recommendations for Reducing the Risk of HIV Transmission by Blood and Blood Products, 2020: Revised guidance document providing blood establishments that collect blood or blood components, including Source Plasma, with revised donor deferral recommendations for individuals with increased risk for transmitting HIV infection 